Class I and Class II Lanthipeptides Produced by Bacillus spp.
The increasing number of multidrug-resistant pathogens, along with the small number of new antimicrobials under development, leads to an increased need for novel alternatives. Class I and class II lanthipeptides (also known as lantibiotics) have been considered promising alternatives to classical an...
| Autor principal: | |
|---|---|
| Outros Autores: | , |
| Formato: | article |
| Idioma: | eng |
| Publicado em: |
1000
|
| Texto completo: | http://hdl.handle.net/10773/16760 |
| País: | Portugal |
| Oai: | oai:ria.ua.pt:10773/16760 |